does glp 1 help with hot flashes Potential New GLP-1 Side Effects Surfaced via AI Analysis of Reddit Posts GLP-1 Agonists in Perimenopause: Unique

Risk factors for knee and hip OA include age, sex, obesity and cardiometabolic factors, all of which are central features of metabolic dysfunction

Below are some key examples from the scientific literature: GLP-1 and Obesity/T2D: GIP and Obesity/T2D: Dual GLP-1/GIP Agonism: Clinical Trials: These literature sources provide a solid background for the roles of GLP-1 and GIP in the context of obesity and T2D and the clinical rationale for their use as therapeutic targets in these conditions

Jensen, C

Access to GLP-1 medications for weight management in the UK involves understanding both licensing (what the medicines are approved for) and NHS commissioning (who can receive them on the NHS)

Most patients find that after 4 to 6 weeks, hunger levels decrease significantly, making it easier to manage portion sizes and reduce overeating